Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TREPROSTINIL
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants
- Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- A Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- An Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension
- Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
- A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
- A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
- A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
- Telemonitoring to Treat Group 2 Pulmonary Hypertension
- Single-Dose, Open Label Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)
- Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
- Effect of BIA 5-1058 on the Steady State Pharmacokinetics of Treprostinil
- A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
- Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
- Single Ascending Dose Study for Evaluation of Safety, Tolerability and Pharmacokinetics of L606
- Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation
- Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil
- Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso
- Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil
- Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial Hypertension
- Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension
- A Safety, Tolerability and Pharmacokinetics Study of TransCon Treprostinil in Healthy Adult Male Volunteers
- Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
- Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers
- EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
- A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
- Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers
- Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil
- Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI
- Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
- Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF
- Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
- Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD
- Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension
- Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery
- Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID)
- A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese Participants
- Acute Effects of Inhaled Treprostinil in Fontan Patients
- Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
- An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
- Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
- Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis
- Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
- Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
- Study to Assess the Tolerability and the Safety of the Transition From Inhaled Treprostinil to Oral Selexipag in Patients With Pulmonary Arterial Hypertension
- Treprostinil Sodium Inhalation for Patients At High Risk for ARDS
- Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers
- Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years
- Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn
- Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso
- Dose Escalation, MTD, Safety and PK Study of a Single Dose SC Injection of TransCon PEG Treprostinil in Healthy Male Volunteers
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
- Beraprost-314d Added-on to Tyvaso® (BEAT)
- Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
- A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
- Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Remodulin® to Oral Treprostinil Transition
- An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy
- Inhaled Treprostinil for PAH: Open-label Extension
- Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
- Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study
- Safety and Efficacy of Treprostinil in Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplantation
- Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®
- Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
- Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)
- A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).
- Treprostinil Combined With Tadalafil for Pulmonary Hypertension
- Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
- Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies
- The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
- A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers
- Comparative Bioavailability of Treprostinil Diethanolamine Manufactured by Two Independent Facilities
- Pharmacokinetic Linearity and Comparative Bioavailability of Treprostinil Diethanolamine
- The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil
- A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension
- Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers
- A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
- An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension
- Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil
- Effect of Food on the Pharmacokinetics of Oral Treprostinil
- Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis
- Open-Label Study of Oral Treprostinil in Digital Ulcers
- Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
- FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
- Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects
- Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
- Safety Study of UT-15C SR (Oral Treprostinil) in Patients Undergoing a Lower Limb Endovascular Procedure
- Rapid Switch From Flolan to Remodulin in the Outpatient Clinic
- Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
- Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- UT-15C SR in the Treatment of Critical Limb Ischemia
- Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH
- Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to Remodulin
- FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)
- FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)
- Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
- Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization Procedures
Clinical trials list
click for details